Advanced Enzyme Technologies Limited

Web: advancedenzymes.com NSE: ADVENZYMES BSE: 540025 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

300 4(1%)

Volume

3L as on 23, Jun

Open

358

High

362

Low

358

296

VWAP

376

52 Week High

419

52 Week Low

252

Viand Research Rating

Quality Score

21/100

Growth Score

24/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

3,364

No. of Shares

11.2

P/E

43.74

P/B

7.15

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

16.35

ROCE

Profit Growth

Listing Date

01-Aug-16

Promoter Holding

43.25%

FII Holding

26.7%

DII Holding

4.77%

Price Chart

Price Performance

1 Week2%

1 Month0%

3 Months40%

6 Months28%

1 Year28%

YTD28%

Moving Average

5 Day SMA374

10 Day SMA371

20 Day SMA373

30 Day SMA373

50 Day SMA355

61 Day SMA340

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	390	378	385	389
Resistance 2	385	377	381	385
Resistance 1	380	376	379	379
Pivot Point	375	375	375	374
Support 1	370	374	371	369
Support 2	365	373	369	364
Support 3	360	372	365	359

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 43.25%	(0.21) 43.26%	(0.01) 43.04%	(0.01) 43.08%	(0.01) 43.08%	(0.21) 43.08%	(0.01) 42.92%	(-0.11) 42.95%	(-0.51) 43.02%	(-0.11) 43.50%	(-2.31) 43.62%	(-0.61) 45.92%	(-3.41) 46.52%	(0.01) 49.88%	(0.01) 49.88%	(-2.81) 49.88%	(0.01) 52.70%	(0.01) 52.70%	(0.21) 52.71%	(0.01) 52.55%
FIIs	(1.21) 26.70%	(-0.41) 25.50%	(0.41) 25.85%	(2.01) 25.41%	(11.61) 23.45%	(-0.71) 11.90%	(-0.11) 12.57%	(0.61) 12.63%	(-11.01) 12.03%	(0.51) 23.01%	(0.31) 22.54%	(0.41) 22.27%	(0.01) 21.89%	(0.11) 21.86%	(0.11) 21.74%	(3.01) 21.68%	(0.71) 18.72%	(1.61) 18.01%	(0.11) 16.39%	(0.01) 16.27%
DIIs	(-0.61) 4.77%	(-0.11) 5.41%	(-0.91) 5.51%	(-2.01) 6.41%	(0.31) 8.45%	(0.01) 8.19%	(0.21) 8.17%	(-0.11) 8.02%	(0.51) 8.08%	(0.61) 7.56%	(0.51) 6.98%	(-1.11) 6.49%	(1.91) 7.58%	(0.11) 5.73%	(0.01) 5.64%	(-0.71) 5.60%	(-0.61) 6.26%	(-2.11) 6.90%	(0.31) 8.99%	(0.01) 8.66%
Public	25.28%	25.85%	25.62%	25.09%	25.00%	36.82%	36.31%	36.40%	36.87%	25.95%	26.88%	25.34%	24.02%	22.54%	22.76%	22.86%	22.32%	22.38%	21.91%	22.52%
No. of Shareholders	63,599	66,193	68,051	69,637	67,589	65,322	67,351	66,758	65,222	68,640	73,034	72,642	75,052	77,537	81,183	84,277	84,376	86,573	84,346	87,112

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	190	203	172	185	186	167	169	146	155	158	161	158	147	139	142	139	121	132	134	127	137
Sales Growth % (YoY)	2.1%	21.6%	1.7%	26.3%	20.3%	5.9%	5.1%	-7.4%	4.9%	13.8%	13.2%	13.8%	21.6%	5.3%	6.4%	9.1%	-11.6%	-1.1%	-3%	5.6%	24%
Sales Growth % (QoQ)	-6.4%	18%	-7%	-0.5%	11.4%	-1.2%	15.8%	-5.8%	-1.9%	-1.9%	1.9%	7.5%	5.8%	-2.1%	2.2%	14.9%	-8.3%	-1.5%	5.5%	-7.3%	-
Expenses	139	140	123	124	129	122	114	104	103	102	107	107	103	95	100	99	90	91	85	78	74
Operating Profit	51	63	49	60	56	46	55	42	51	55	54	51	44	44	42	40	31	40	49	49	63
OPM %	27	31	29	33	30	27	33	29	33	35	33	32	30	32	29	29	26	31	37	39	46
Other Income	13	7	20	10	9	9	8	10	7	-6	14	6	7	7	9	4	2	3	1	1	1
Interest	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0	0	0
Depreciation	10	10	10	10	10	10	9	9	9	9	9	9	9	8	9	9	9	9	9	9	8
Profit before tax	54	60	58	60	55	43	53	42	49	40	59	48	41	42	40	34	24	34	41	41	55
Tax %	28	24	26	25	26	38	27	21	28	25	28	27	29	24	31	23	26	26	31	27	27
Net Profit	39	45	43	45	40	27	39	33	35	30	42	35	29	32	28	26	18	25	29	30	40
Net Profit Growth % (QoQ)	-13.3%	4.7%	-4.4%	12.5%	48.1%	-30.8%	18.2%	-5.7%	16.7%	-28.6%	20%	20.7%	-9.4%	14.3%	7.7%	44.4%	-28%	-13.8%	-3.3%	-25%	-
Net Profit Growth % (YoY)	-2.5%	66.7%	10.3%	36.4%	14.3%	-10%	-7.1%	-5.7%	20.7%	-6.2%	50%	34.6%	61.1%	28%	-3.4%	-13.3%	-55%	-	-	-	-
TTM Net Profit	172	173	155	151	139	134	137	140	142	136	138	124	115	104	97	98	102	124	99	70	0
EPS in Rs	3.31	3.84	3.8	3.87	3.57	2.37	3.37	2.94	3.05	2.53	3.74	3.08	2.58	2.87	2.63	2.34	1.6	2.19	2.46	2.66	3.4

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	746	637	624	541	529	502	444	420	391	329	293	222	239	219
Sales Growth %	17.1%	2.1%	15.4%	2.1%	5.5%	13%	5.8%	7.3%	18.8%	12.3%	32.2%	-7.1%	8.9%	28.2%
Expenses	515	441	418	382	327	269	241	236	226	177	155	131	189	130
Operating Profit	230	196	206	158	203	232	203	184	165	152	138	91	50	90
OPM %	31	31	33	29	38	46	46	44	42	46	47	41	21	41
Other Income	46	33	21	21	6	9	6	5	1	3	-3	1	1	4
Interest	4	5	4	3	3	3	4	5	9	4	8	9	13	10
Depreciation	40	37	35	35	35	28	26	21	18	13	9	9	10	8
Profit before tax	233	187	188	140	171	210	179	162	139	137	118	74	28	76
Tax %	25	28	27	26	28	28	26	28	33	32	35	31	23	34
Net Profit	174	134	137	104	124	151	133	116	94	93	77	51	21	50
Net Profit Growth %	29.9%	-2.2%	31.7%	-16.1%	-17.9%	13.5%	14.7%	23.4%	1.1%	20.8%	51%	142.9%	-58%	-
EPS in Rs	15.07	11.72	11.92	9.45	10.7	13.09	11.58	9.95	8.07	8.2	6.97	4.6	1.85	4.52
Dividend Payout %	36	44	43	11	9	7	5	6	6	5	3	4	6	7

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	157	142	141	140	122	163	141	129	116	107	93	54	43	41
Cash from Investing Activity	-72	-89	-65	-286	2	-27	-43	-124	-60	-60	-10	-15	-25	-40
Cash from Financing Activity	-70	-73	-59	-26	-48	-26	-39	-43	-2	-65	-63	-36	-20	-3
Net Cash Flow	15	-20	17	-171	75	109	60	-38	54	-18	21	2	-1	-2

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	22	22	22	22	22	22	22	22	22	22	22	22	22	22	22	22
Reserves	1610	1462	1398	1319	1302	1213	1066	948	817	657	537	442	256	188	145	140
Borrowings	32	35	39	47	47	34	35	23	28	35	67	54	101	115	167	186
Other Liabilities	170	173	151	161	150	142	137	153	104	91	102	65	71	92	73	48
Total Liabilities	1834	1692	1611	1549	1521	1411	1260	1146	971	805	727	583	450	417	406	396
Fixed Assets	692	683	679	665	650	649	619	601	563	495	491	421	285	287	287	287
CWIP	51	31	22	34	41	22	15	10	10	10	11	8	7	5	2	2
Investments	584	529	480	396	403	360	102	121	124	111	0	0	0	0	0	0
Other Assets	507	449	430	454	427	380	524	413	275	188	226	153	158	125	117	107
Total Assets	1834	1692	1611	1549	1521	1411	1260	1146	971	805	727	583	450	417	406	396

Delivery

Delivery Data: ADVENZYMES

#	Date	291 21% 353	Value (Cr)	Q/T 49	Del 50	Del 19
1	4-Sep	293	8	67	59	4
2	3-Sep	296	4	58	54	2
3	2-Sep	293	6	59	65	4
4	1-Sep	295	5	44	64	3
5	31-Aug	294	5	49	68	4
6	28-Aug	300	6	65	57	3
7	27-Aug	298	6	49	58	4
8	26-Aug	297	5	44	52	3
9	25-Aug	300	6	55	54	3
10	24-Aug	302	5	49	49	2
11	21-Aug	300	14	43	62	9
12	20-Aug	303	9	54	59	5
13	19-Aug	305	6	47	62	4
14	18-Aug	303	6	58	74	5
15	17-Aug	306	6	52	58	3
16	14-Aug	304	10	55	52	5
17	13-Aug	301	5	45	62	3
18	12-Aug	302	12	50	46	6
19	11-Aug	298	11	47	60	7
20	10-Aug	295	35	45	58	21
21	7-Aug	324	6	36	60	3
22	6-Aug	330	6	40	63	3
23	5-Aug	333	11	48	59	6
24	4-Aug	323	9	44	56	5
25	3-Aug	324	59	53	27	16
26	31-Jul	315	7	38	58	4
27	30-Jul	306	4	40	63	2
28	29-Jul	311	5	35	58	3
29	28-Jul	311	4	36	66	3
30	27-Jul	317	6	34	57	3
31	24-Jul	317	3	22	55	2
32	23-Jul	314	9	40	59	5
33	22-Jul	313	6	42	61	4
34	21-Jul	321	3	26	53	2
35	20-Jul	319	3	33	59	2
36	17-Jul	321	8	33	55	4
37	16-Jul	325	4	35	60	2
38	15-Jul	328	3	28	52	2
39	14-Jul	324	6	33	62	4
40	13-Jul	331	8	41	48	4
41	10-Jul	330	5	28	61	3
42	9-Jul	324	5	26	52	3
43	8-Jul	319	9	38	45	4
44	7-Jul	320	10	42	59	6
45	6-Jul	323	6	31	58	4
46	3-Jul	318	24	39	51	12
47	2-Jul	313	49	77	62	30
48	1-Jul	315	32	67	71	22
49	30-Jun	308	67	71	55	37
50	29-Jun	321	40	63	67	27

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	3,364c	48c	1.45
03-Sep	3,316c	8c	0.25
01-Sep	3,324c	7c	0.20
31-Aug	3,331c	13c	0.39
27-Aug	3,318c	55c	1.63
26-Aug	3,373c	24c	0.72
25-Aug	3,349c	28c	0.83
24-Aug	3,377c	38c	1.11
21-Aug	3,415c	12c	0.34
19-Aug	3,427c	34c	1.01
18-Aug	3,392c	19c	0.56
17-Aug	3,411c	19c	0.54
14-Aug	3,393c	2c	0.07
13-Aug	3,391c	9c	0.26
12-Aug	3,382c	67c	2.03
11-Aug	3,315c	37c	1.10
10-Aug	3,351c	276c	7.59
07-Aug	3,627c	63c	1.70
06-Aug	3,690c	73c	2.01
04-Aug	3,617c	78c	2.22
31-Jul	3,538c	113c	3.28
30-Jul	3,426c	44c	1.26
29-Jul	3,470c	19c	0.53
28-Jul	3,488c	57c	1.61
27-Jul	3,545c	11c	0.30
24-Jul	3,556c	0	0

Stock Checklist

Price is above from 52 week high low average: 29%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 22 fund scheme(s) across 9 fund house(s) as of Aug26 · Total value ₹132 Cr · 2 increasing / 6 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
UTI Mutual Fund	2	1.22%	-0.14%	67.6
ICICI Prudential Mutual Fund	2	1.86%	+0.02%	50.7
Motilal Oswal Mutual Fund	4	0.16%	-0.04%	8
Bank of India Mutual Fund	3	0.09%	-0.01%	3.7
Jio BlackRock Mutual Fund	1	0.07%	-	2.1
Groww Mutual Fund	2	0.01%	-	0.1
Bandhan Mutual Fund	4	0.02%	-0.03%	0
Angel One Mutual Fund	2	0.00%	-	0
Mirae Asset Mutual Fund	2	0.00%	-	0

Advanced Enzyme Technologies Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements